Dexamethasone for Pediatric Critical Asthma: A Multicenter Descriptive Study
Systemic corticosteroids are vital to critical asthma management. While intravenous methylprednisolone is routinely used in the pediatric intensive care unit (PICU) setting, recent data supports dexamethasone as an alternative. Using the Pediatric Health Information System (PHIS) registry, we assess...
Saved in:
Published in | Journal of intensive care medicine p. 8850666221082540 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
01.11.2022
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | Systemic corticosteroids are vital to critical asthma management. While intravenous methylprednisolone is routinely used in the pediatric intensive care unit (PICU) setting, recent data supports dexamethasone as an alternative. Using the Pediatric Health Information System (PHIS) registry, we assessed trends and variation in corticosteroid prescribing among children hospitalized for critical asthma.
We performed a multicenter retrospective cohort study using PHIS data among children 3-17 years of age admitted for critical asthma from 2011 through 2019. Primary outcomes were corticosteroid prescribing rates by year and participating sites. Exploratory outcomes were corticosteroid-related adverse effects, rates of adjunctive pharmaceutical and respiratory interventions, mortality and length of stay.
Of the 49 children's hospitals assessed, 26 907 encounters were included for study. Mean dexamethasone exposure rates were 18.1 ± 2.4% where 2.4 ± 1.2% represented dexamethasone-alone prescribing. Dexamethasone alone prescribing exhibited a linear trend (annual increase of 0.5 ± 0.1% annually
= 0.845) without correlation to cumulative site critical asthma admission rates. Compared to encounters prescribed solely methylprednisolone or a combination of dexamethasone and methylprednisolone, subjects provided dexamethasone alone had reduced asthma severity indices, length of stay, and exposure rates to adjunctive asthma interventions. Adverse events were rare and the dexamethasone-alone group less frequently experienced gastritis and hyperglycemia.
In this multicenter retrospective study from 49 children's hospitals, dexamethasone prescribing rates appear increasing for pediatric critical asthma. Observed variability in corticosteroid prescribing implies a continued need for controlled prospective comparative analyses to define ideal corticosteroid regimens for pediatric critical asthma. |
---|---|
AbstractList | Systemic corticosteroids are vital to critical asthma management. While intravenous methylprednisolone is routinely used in the pediatric intensive care unit (PICU) setting, recent data supports dexamethasone as an alternative. Using the Pediatric Health Information System (PHIS) registry, we assessed trends and variation in corticosteroid prescribing among children hospitalized for critical asthma.
We performed a multicenter retrospective cohort study using PHIS data among children 3-17 years of age admitted for critical asthma from 2011 through 2019. Primary outcomes were corticosteroid prescribing rates by year and participating sites. Exploratory outcomes were corticosteroid-related adverse effects, rates of adjunctive pharmaceutical and respiratory interventions, mortality and length of stay.
Of the 49 children's hospitals assessed, 26 907 encounters were included for study. Mean dexamethasone exposure rates were 18.1 ± 2.4% where 2.4 ± 1.2% represented dexamethasone-alone prescribing. Dexamethasone alone prescribing exhibited a linear trend (annual increase of 0.5 ± 0.1% annually
= 0.845) without correlation to cumulative site critical asthma admission rates. Compared to encounters prescribed solely methylprednisolone or a combination of dexamethasone and methylprednisolone, subjects provided dexamethasone alone had reduced asthma severity indices, length of stay, and exposure rates to adjunctive asthma interventions. Adverse events were rare and the dexamethasone-alone group less frequently experienced gastritis and hyperglycemia.
In this multicenter retrospective study from 49 children's hospitals, dexamethasone prescribing rates appear increasing for pediatric critical asthma. Observed variability in corticosteroid prescribing implies a continued need for controlled prospective comparative analyses to define ideal corticosteroid regimens for pediatric critical asthma. |
Author | McKinley, Scott D Sochet, Anthony A Sellers, Austin R Sanchez-Teppa, Beatriz Roddy, Meghan R Darville, Kristina K |
Author_xml | – sequence: 1 givenname: Austin R surname: Sellers fullname: Sellers, Austin R organization: Institute for Clinical and Translational Research, 7582Johns Hopkins All Children's Hospital, St. Petersburg, FL, USA – sequence: 2 givenname: Meghan R surname: Roddy fullname: Roddy, Meghan R organization: Department of Pharmacy, 7582Johns Hopkins All Children's Hospital, St. Petersburg, FL, USA – sequence: 3 givenname: Kristina K surname: Darville fullname: Darville, Kristina K organization: Department of Medicine, Division of Pediatric Critical Care Medicine, 7582Johns Hopkins All Children's Hospital, St. Petersburg, FL, USA – sequence: 4 givenname: Beatriz surname: Sanchez-Teppa fullname: Sanchez-Teppa, Beatriz organization: Department of Medicine, Division of Pediatric Critical Care Medicine, 7582Johns Hopkins All Children's Hospital, St. Petersburg, FL, USA – sequence: 5 givenname: Scott D surname: McKinley fullname: McKinley, Scott D organization: Department of Medicine, Division of Pediatric Pulmonology and Sleep Medicine, 7582Johns Hopkins All Children's Hospital, St. Petersburg, FL, USA – sequence: 6 givenname: Anthony A orcidid: 0000-0002-6290-4975 surname: Sochet fullname: Sochet, Anthony A organization: Department of Anesthesiology and Critical Care Medicine, 1500Johns Hopkins University School of Medicine, Baltimore, MD, USA |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35236174$$D View this record in MEDLINE/PubMed |
BookMark | eNo1j8tKAzEYRoMo9qIP4EbyAqO5J-OutPUCIwrqumSSPzQy0w5JRuzbW1BXHxwOB74ZOt3td4DQFSU3lGp9S4yRRCnFGCWGSUFO0JRKJisqTD1Bs5w_CaGccXqOJlwyrqgWU9Ss4Nv2ULY2H3s47BN-BR9tSdHhZYolOtvhRS7b3t7hBX4euyOCXYGEV5BdikOJX4DfyugPF-gs2C7D5d_O0cf9-n35WDUvD0_LRVM5LkipWkm4Fw547VvXSqmZIUZIWuvAlFFAa18r4nUdQivC0VFMuuCMF6CNJcDm6Pq3O4xtD34zpNjbdNj832I_bv5PtQ |
CitedBy_id | crossref_primary_10_1097_MOP_0000000000001351 crossref_primary_10_1097_PCC_0000000000003347 crossref_primary_10_1002_ppul_26386 |
ContentType | Journal Article |
DBID | NPM |
DOI | 10.1177/08850666221082540 |
DatabaseName | PubMed |
DatabaseTitle | PubMed |
DatabaseTitleList | PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1525-1489 |
ExternalDocumentID | 35236174 |
Genre | Journal Article |
GroupedDBID | --- .2E .2J .2N .XZ 01A 0R~ 1OC 1~K 29K 31R 31U 31X 31Z 4.4 53G 54M 5GY 5RE 5VS AABOD AACMV AACTG AAEWN AAGMC AAJPV AAKGS AAMGE AAPEO AARDL AATAA AATBZ AAUAS ABAFQ ABAWP ABCCA ABHQH ABJNI ABLUO ABPNF ABQKF ABQXT ABVFX ACARO ACDXX ACFEJ ACGFS ACGZU ACJER ACJTF ACLFY ACLZU ACOXC ACROE ACSIQ ACTQU ACUAV ACUIR ACXKE ACXMB ADBBV ADRRZ AECGH AEDTQ AEKYL AENEX AEPTA AERKM AESZF AEUHG AEUIJ AEWDL AEWHI AFMOU AFQAA AGKLV AGWFA AIIQI AIOMO AJXAJ ALKWR ALMA_UNASSIGNED_HOLDINGS ALTZF AMCVQ ANDLU ARTOV AUTPY AUVAJ AYAKG B3H B8R B8Z B94 BBRGL BDDNI BKIIM BPACV BSEHC BWJAD BYIEH C45 CS3 D-I DB0 DC. DF0 DO- DV7 DV9 EBS EJD EMOBN F5P FHBDP GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION H13 HF~ HZ~ IAO IEA IHR INH INR IVC J8X JCYGO K.F M4V N9A NPM O9- OVD P.B P2P Q1R Q7L Q7U Q83 ROL S01 SCNPE SDB SFC SFK SFT SGO SGR SGV SGZ SHG SNB SPJ SPP SPQ SPV STM TEORI WH7 YFH |
ID | FETCH-LOGICAL-c340t-b503d4ce39dbcb557280845197f2686e19d960d79ffb4fdbc625cfc8d4e78a0e2 |
IngestDate | Sat Sep 28 08:20:16 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | dexamethasone corticosteroids pediatrics status asthmaticus critical asthma methylprednisolone pediatric intensive care unit |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c340t-b503d4ce39dbcb557280845197f2686e19d960d79ffb4fdbc625cfc8d4e78a0e2 |
ORCID | 0000-0002-6290-4975 |
PMID | 35236174 |
ParticipantIDs | pubmed_primary_35236174 |
PublicationCentury | 2000 |
PublicationDate | 2022-11-01 |
PublicationDateYYYYMMDD | 2022-11-01 |
PublicationDate_xml | – month: 11 year: 2022 text: 2022-11-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Journal of intensive care medicine |
PublicationTitleAlternate | J Intensive Care Med |
PublicationYear | 2022 |
SSID | ssj0013231 |
Score | 2.3829894 |
Snippet | Systemic corticosteroids are vital to critical asthma management. While intravenous methylprednisolone is routinely used in the pediatric intensive care unit... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 8850666221082540 |
Title | Dexamethasone for Pediatric Critical Asthma: A Multicenter Descriptive Study |
URI | https://www.ncbi.nlm.nih.gov/pubmed/35236174 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1JS8NAFB6qgngR913m4E1G0mQmmfFWXBCxHrSCN5nVCrYWrSK9-sd9k0ljWtwvIWSSkMz35eVt8x5CO5FjijsuiKobS6hTlkjFUmJiEcUm1TKW3lBsnqcnV_T0ml3Xam-VrKXnvtrTg0_XlfwHVTgGuPpVsn9AtrwpHIB9wBe2gDBsf4XxoX2VvgW0BKU5FO8uO2_slj0MGk_9dkeGFej5clufj2kfQdIUEuMlZBOOxHdPRwtKhCT3PEtsPBh_6T3_oc-a95vcdT9SEC8eTBDhTXvblpWBQwkC6j4kMgcp05UVfysQsW0HpGV7vdAY2vpXGlQdFGDb1ksHhS2EaswImF2iIii5r5SXpjFYnN5GjT6X5nk8OfruXJi9XieHFzTJBNQx-vPoWIHt4dAEmsi4F5Ln3uFTBqKSehEMz-t0jT_LDJoeXj9mmOQKSmsOzRaI4UagyTyq2e4Cmm4WcC2isxG2YGALLtmCh2zBgS37uIErXMEVruCcK0vo6viodXBCil4aRCc06hPFosRQbRNhlFaM-a5k3JcWylyc8tTWhQFb1mTCOUUdnAN2sXaaG2ozLiMbL6PJLjzdKsLCUCoUTRQH1TADhU87ZhzTLPX_B-HW0EqYh5teKJhyM5yh9S9HNtDMB3U20ZSDL9RugbrXV9s5IO-Qf1K2 |
link.rule.ids | 786 |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Dexamethasone+for+Pediatric+Critical+Asthma%3A+A+Multicenter+Descriptive+Study&rft.jtitle=Journal+of+intensive+care+medicine&rft.au=Sellers%2C+Austin+R&rft.au=Roddy%2C+Meghan+R&rft.au=Darville%2C+Kristina+K&rft.au=Sanchez-Teppa%2C+Beatriz&rft.date=2022-11-01&rft.eissn=1525-1489&rft.spage=8850666221082540&rft_id=info:doi/10.1177%2F08850666221082540&rft_id=info%3Apmid%2F35236174&rft_id=info%3Apmid%2F35236174&rft.externalDocID=35236174 |